SEARCH

SEARCH BY CITATION

References

  • 1
    Fass R, Hell R, Sampliner RE et al. Effect of ambulatory 24-hour esophageal pH monitoring on reflux-provoking activities. Dig Dis Sci 1999; 44: 22639.
  • 2
    Gillies RS, Stratford JM, Booth MI, Dehn TC. Oesophageal pH monitoring using the Bravo catheter-free radio capsule. Eur J Gastroenterol Hepatol 2007; 19: 5763.
  • 3
    Sweis R, Fox M, Anggiansah R et al. Patient acceptance and clinical impact of Bravo monitoring in patients with previous failed catheter-based studies. Aliment Pharmacol Ther 2009; 29: 66976.
  • 4
    Scarpulla G, Camilleri S, Galante P, Manganaro M, Fox M. The impact of prolonged pH measurements on the diagnosis of gastroesophageal reflux disease: 4-day wireless pH studies. Am J Gastroenterol 2007; 102: 26427.
    Direct Link:
  • 5
    Prakash C, Clouse RE. Value of extended recording time with wireless pH monitoring in evaluating gastroesophageal reflux disease. Clin Gastroenterol Hepatol 2005; 3: 32934.
  • 6
    Pandolfino JE, Richter JE, Ours T, Guardino JM, Chapman J, Kahrilas PJ. Ambulatory esophageal pH monitoring using a wireless system. Am J Gastroenterol 2003; 98: 7409.
    Direct Link:
  • 7
    National Institute for Health and Clinical Excellence (NICE). Catheterless Oesophageal pH Monitoring, Interventional Procedure Guidance 187. London, UK: NICE, 2006.
  • 8
    Bodger K, Trudgill N. Guidelines for Oesophageal Manometry and pH Monitoring. London (UK): British Society of Gastroenterology (BSG), 2006.
  • 9
    Pandolfino JE, Zhang Q, Schreiner MA, Ghosh S, Roth MP, Kahrilas PJ. Acid reflux event detection using the Bravo wireless versus the Slimline catheter pH systems: why are the numbers so different? Gut 2005; 54: 168792.
  • 10
    Johnsson F, Joelsson B, Isberg PE. Ambulatory 24 hour intraesophageal pH-monitoring in the diagnosis of gastroesophageal reflux disease. Gut 1987; 28: 114550.
  • 11
    Richter JE, Bradley LA, DeMeester TR, Wu WC. Normal 24-hr ambulatory esophageal pH values. Influence of study center, pH electrode, age, and gender. Dig Dis Sci 1992; 37: 84956.
  • 12
    Weusten BL, Roelofs JM, Akkermans LM, Van Berge-Henegouwen GP, Smout AJ. The symptom-association probability: an improved method for symptom analysis of 24-hour esophageal pH data. Gastroenterology 1994; 107: 17415.
  • 13
    Lee JD, Anggiansah A, Anggiansah R, Young A, Wong T, Fox M. The effects of age on the gastro-esophageal junction, esophageal motility and reflux disease. Clin Gastroenterol Hepatol 2007; 5: 13928.
  • 14
    Labenz J, Nocon M, Lind T et al. Prospective follow-up data from the ProGERD study suggest that GERD is not a categorial disease. Am J Gastroenterol 2006; 101: 245762.
    Direct Link:
  • 15
    Mainie I, Tutuian R, Castell DO. Comparison between the combined analysis and the DeMeester Score to predict response to PPI therapy. J Clin Gastroenterol 2006; 40: 6025.
  • 16
    Wong WM, Bautista J, Dekel R et al. Feasibility and tolerability of transnasal/per-oral placement of the wireless pH capsule vs. traditional 24-h oesophageal pH monitoring – a randomized trial. Aliment Pharmacol Ther 2005; 21: 15563.
  • 17
    Bredenoord AJ, Weusten BL, Smout AJ. Symptom association analysis in ambulatory gastro-oesophageal reflux monitoring. Gut 2005; 54: 18107.
  • 18
    Fox M, Schwizer W. Making sense of oesophageal contents. Gut 2008; 57: 4358.
  • 19
    Campos GM, Peters JH, DeMeester TR et al. Multivariate analysis of factors predicting outcome after laparoscopic Nissen fundoplication. J Gastrointest Surg 1999; 3: 292300.
  • 20
    Mainie I, Tutuian R, Agrawal A, Adams D, Castell DO. Combined multichannel intraluminal impedance-pH monitoring to select patients with persistent gastro-oesophageal reflux for laparoscopic Nissen fundoplication. Br J Surg 2006; 93: 14837.
  • 21
    Broeders JA, Draaisma WA, Bredenoord AJ et al. Oesophageal acid hypersensitivity is not a contraindication to Nissen fundoplication. Br J Surg 2009; 96: 102330.
  • 22
    Connor J, Richter J. Increasing yield also increases false positives and best serves to exclude GERD. Am J Gastroenterol 2006; 101: 4603.
    Direct Link:
  • 23
    Mainie I, Tutuian R, Shay S et al. Acid and non-acid reflux in patients with persistent symptoms despite acid suppressive therapy: a multicentre study using combined ambulatory impedance-pH monitoring. Gut 2006; 55: 1398402.